Total Payments
$2,929
2024 Payments
$205.79
Companies
34
Transactions
194
Medicare Patients
32,234
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$2,888 (98.6%)
Education$41.34 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,888 | 189 | 98.6% |
| Education | $41.34 | 5 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OPKO Pharmaceuticals, LLC | $421.76 | 34 | $0 (2023) |
| Relypsa, Inc. | $316.87 | 22 | $0 (2020) |
| Amgen Inc. | $258.22 | 15 | $0 (2023) |
| Keryx Biopharmaceuticals, Inc. | $253.07 | 13 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $215.41 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $172.09 | 11 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $101.73 | 7 | $0 (2019) |
| ARBOR PHARMACEUTICALS, INC. | $98.81 | 7 | $0 (2019) |
| Aurinia Pharma U.S., Inc. | $93.87 | 6 | $0 (2023) |
| Genentech USA, Inc. | $82.45 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $205.79 | 14 | Otsuka America Pharmaceutical, Inc. ($70.20) |
| 2023 | $136.07 | 9 | Mallinckrodt Hospital Products Inc. ($34.71) |
| 2022 | $253.32 | 14 | Aurinia Pharma U.S., Inc. ($45.89) |
| 2021 | $335.14 | 21 | AstraZeneca Pharmaceuticals LP ($66.24) |
| 2020 | $91.40 | 6 | OPKO Pharmaceuticals, LLC ($25.99) |
| 2019 | $640.64 | 50 | Relypsa, Inc. ($161.74) |
| 2018 | $631.92 | 42 | OPKO Pharmaceuticals, LLC ($111.02) |
| 2017 | $634.89 | 38 | Keryx Biopharmaceuticals, Inc. ($189.91) |
All Payment Transactions
194 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Immunology | ||||||
| 11/12/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Nephrology | ||||||
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Immunology | ||||||
| 09/22/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: NEPHROLOGY | ||||||
| 08/29/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.78 | General |
| 08/28/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 08/28/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 08/06/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 07/29/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: NEPHROLOGY | ||||||
| 03/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Diabetes | ||||||
| 02/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: NEPHROLOGY | ||||||
| 02/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Diabetes | ||||||
| 02/05/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: NEPHROLOGY | ||||||
| 12/19/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Diabetes | ||||||
| 11/21/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/17/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Hematology | ||||||
| 05/01/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: KRYSTEXXA | ||||||
| 04/20/2023 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Genetic Disease | ||||||
| 03/27/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: NEPHROLOGY | ||||||
| 03/21/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Inflammation | ||||||
| 10/18/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/20/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 7,012 | 11,807 | $2.9M | $396,494 |
| 2022 | 52 | 8,565 | 20,115 | $1.7M | $478,417 |
| 2021 | 45 | 7,780 | 18,662 | $1.3M | $362,433 |
| 2020 | 45 | 8,877 | 21,621 | $1.7M | $423,287 |
Total Patients
32,234
Total Services
72,205
Medicare Billing
$1.7M
Procedure Codes
189
All Medicare Procedures & Services
189 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 65 | 512 | $1.0M | $135,962 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 478 | 666 | $467,572 | $55,451 | 11.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 121 | 324 | $214,248 | $28,954 | 13.5% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 388 | 532 | $131,766 | $21,269 | 16.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 67 | 343 | $117,944 | $15,477 | 13.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 341 | 424 | $75,302 | $12,171 | 16.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 70 | 348 | $92,290 | $11,988 | 13.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 85 | 90 | $86,756 | $11,300 | 13.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 57 | 281 | $73,543 | $9,718 | 13.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 101 | 158 | $69,200 | $9,469 | 13.7% |
| 82610 | Cystatin c (enzyme inhibitor) level | Office | 2023 | 289 | 404 | $44,892 | $7,235 | 16.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 355 | 587 | $37,192 | $6,010 | 16.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 508 | 782 | $36,457 | $5,899 | 16.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 16 | 26 | $42,288 | $5,646 | 13.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 39 | $38,439 | $4,943 | 12.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 391 | 557 | $10,026 | $4,658 | 46.5% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 18 | 760 | $37,620 | $4,222 | 11.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 489 | 732 | $21,207 | $4,103 | 19.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 235 | 235 | $23,575 | $3,946 | 16.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 485 | 725 | $22,533 | $3,647 | 16.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 22 | $26,011 | $3,565 | 13.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $24,666 | $2,898 | 11.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 37 | 55 | $21,882 | $2,890 | 13.2% |
| 84100 | Phosphate level | Office | 2023 | 345 | 563 | $16,012 | $2,593 | 16.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 28 | 84 | $18,255 | $2,502 | 13.7% |
About Dr. Brant Holt, MD
Dr. Brant Holt, MD is a Nephrology healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437123528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brant Holt, MD has received a total of $2,929 in payments from pharmaceutical and medical device companies, with $205.79 received in 2024. These payments were reported across 194 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,888).
As a Medicare-enrolled provider, Holt has provided services to 32,234 Medicare beneficiaries, totaling 72,205 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 189 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Chattanooga, TN
- Active Since 02/15/2006
- Last Updated 05/28/2010
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1437123528
Products in Payments
- Veltassa (Drug) $385.29
- Rayaldee (Drug) $300.85
- Auryxia (Drug) $253.07
- Parsabiv (Biological) $141.25
- RAYALDEE (Drug) $120.91
- ACTHAR (Biological) $119.29
- SAMSCA (Drug) $118.46
- JYNARQUE (Drug) $96.95
- LUPKYNIS (Drug) $93.87
- Velphoro (Drug) $86.21
- Rituxan (Biological) $82.45
- BENLYSTA (Biological) $82.09
- LOKELMA (Drug) $81.80
- FARXIGA (Drug) $78.56
- Edarbi (Drug) $71.41
- JARDIANCE (Drug) $65.66
- Parsabiv (Drug) $64.85
- KRYSTEXXA (Drug) $60.73
- Uloric (Drug) $55.27
- KRYSTEXXA (Biological) $54.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chattanooga
Rohit Gupta, M.d, M.D
Nephrology — Payments: $10,529
Nephrology $10,529
Hans Yehnert, Md, MD
Nephrology — Payments: $5,326
Nephrology $5,326
Nilesh Patel, M.d, M.D
Nephrology — Payments: $3,184
Nephrology $3,184
John Mccarley, M.d, M.D
Nephrology — Payments: $2,939
Nephrology $2,939
Mandeep Grewal, Md, MD
Nephrology — Payments: $2,449
Nephrology $2,449
Claude Galphin, Md, MD
Nephrology — Payments: $2,379
Nephrology $2,379